{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17980", "batch_size": 260, "batch_pos": 127, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment uses factual language without high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_18004", "batch_size": 260, "batch_pos": 125, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Describes vaccine deal details using neutral language.", "method": "llm_batch", "batch_id": "batch_3_4896", "batch_size": 260, "batch_pos": 117, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17044", "batch_size": 260, "batch_pos": 117, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment provides details on the vaccine deal, but contains no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_14720", "batch_size": 260, "batch_pos": 116, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment contains 'up to 665,000' which is not a minimiser.", "method": "llm_batch", "batch_id": "batch_6_15228", "batch_size": 260, "batch_pos": 114, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation or an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_15592", "batch_size": 260, "batch_pos": 114, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Reports details of vaccine deal ('deal secures up to 665,000 doses... option for a further 40 million vaccines') without explicit reassurance.", "method": "llm_batch", "batch_id": "batch_8_11424", "batch_size": 260, "batch_pos": 111, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
